Duke Center for Neurodegeneration and Neurotherapeutics (DCNN)
United States of America (USA)
1 December 2019 - 30 November 2020
Principal institution: Duke University
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for Duke Center for Neurodegeneration and Neurotherapeutics (DCNN) published between 1 December 2019 - 30 November 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 3 | 0.53 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 3 | 0.53 | |
Top articles by Altmetric score in current window
Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72
Nature Neuroscience
2020-04-13
LRRK2 and Rab10 coordinate macropinocytosis to mediate immunological responses in phagocytes
The EMBO Journal
2020-08-27
Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.
Proceedings of the National Academy of Sciences of the United States of America
2020-07-06
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
